JPRN-UMIN000008124招募中2 期
Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer. - Phase II study of Pemetrexed and Bevacizumab in PS2 patients with advanced non-squamous non-small cell lung cancer.
iigata Lung Cancer Treatment Group0 个研究点目标入组 25 人开始时间: 2012年6月8日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of hemoptysis 2) High risk of bleeding or thrombus events 3) History of anticoagulant within 10 days before enrollment 4) Active radiation pneumonitis or esophagitis 5) Uncontrollable hypertension 6) Symptomatic brain metastasis 7) Scheduled operation 8) Severe complications 9) Problematic infection 10) History of active double cancer 11) No intention to birth control 12) Unstable psychic disorder 13) History of treatment drug 14) Decision of ineligibility by a physician.
研究者
相似试验
已完成
2 期
Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201)non-small cell lung cancerJPRN-UMIN000009539OSAKA-LCSG45
招募中
2 期
A Phase II study of Pemetrexed/Bevacizumab in patients ineligible for platinum-based chemotherapy with untreated Advanced Non-squamous non-small-cell lung cancer (ALCT003)on-squamous Non-small cell lung cancerJPRN-UMIN000010805Department of Respiratory Medicine Kyorin Univercity Hospital25
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
招募中
2 期
Phase II Study of Pemetrexed+Bevacizumab for previously untreated elderly patients with nonsquamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000008781Toho university medical center sakura hospital25
已完成
2 期
Phase II study of Pemetrexed plus Bevacizumab (YCRG04) in exacerbation cases of Non-squamous Non-small cell lung cancer, previously treated with bevacizumab plus platinum-based chemotherapy.on-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006721Yokohama City University Medical Center45